Ultralife (ULBI) Cost of Revenue (2010 - 2026)

Ultralife's Cost of Revenue history runs 17 years deep, the most recent figure standing at $37.3 million for Q1 2026.

• In Q1 2026, Cost of Revenue fell 1.75% year-over-year to $37.3 million; the TTM figure through Mar 2026 stood at $144.5 million (up 49.63% YoY), while the FY2025 annual figure was $145.1 million, up 18.83% from the prior year.
• Cost of Revenue was $37.3 million for Q1 2026 at Ultralife, up from $36.4 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $38.0 million in Q1 2025 to a low of $120000.0 in Q4 2024.
• Historically, Cost of Revenue has averaged $29.0 million across 5 years, with a median of $30.5 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Cost of Revenue tumbled 99.64% in 2024, then surged 30254.17% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $28.0 million in 2022, then rose by 18.27% to $33.1 million in 2023, then sank by 99.64% to $120000.0 in 2024, then soared by 30254.17% to $36.4 million in 2025, then gained by 2.5% to $37.3 million in 2026.
• The last three Cost of Revenue figures came in at $37.3 million (Q1 2026), $36.4 million (Q4 2025), and $33.8 million (Q3 2025), per Business Quant data.